InvestorsObserver
×
News Home

Do Traders Think ENDRA Life Sciences Inc (NDRA) Can Keep Climbing Thursday?

Thursday, October 12, 2023 11:01 AM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think ENDRA Life Sciences Inc (NDRA) Can Keep Climbing Thursday?

ENDRA Life Sciences Inc (NDRA) stock has gained 4.90% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bearish
ENDRA Life Sciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on NDRA!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With NDRA Stock Today?

ENDRA Life Sciences Inc (NDRA) stock has gained 6.5% while the S&P 500 is lower by -0.04% as of 10:36 AM on Thursday, Oct 12. NDRA is up $0.07 from the previous closing price of $1.00 on volume of 3,146 shares. Over the past year the S&P 500 has gained 21.91% while NDRA is lower by -82.69%. NDRA lost -$3.48 per share in the over the last 12 months.

More About ENDRA Life Sciences Inc

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. Click Here to get the full Stock Report for ENDRA Life Sciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App